A9599 HCPCS Level II code: Radiopharmaceutical, diagnostic, for beta-amyloid positron emission tomography (pet) imaging, per study dose, not otherwise specified
CMS terminated A9599: its last date of service was Dec 31, 2017. It stays here for looking up older claims; newer services need a current code.
Official description
A9599Radiopharmaceutical, diagnostic, for beta-amyloid positron emission tomography (pet) imaging, per study dose, not otherwise specified
Short description: Radioph dx b amyloid pet nos
HCPCS · United States
Notes for A9599
As CMS prints them, with any note A9599 takes from the headings above it.
Note
- CMS processing note 0191: IOM 100-3, CHAPTER 4, 220.6.20.
Medicare details
The indicators CMS publishes with A9599 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Other carrier priced
- Type of service
- Diagnostic radiology
- BETOS category
- Standard imaging - nuclear medicine
- Added
- Jan 1, 2014
- Terminated after
- Dec 31, 2017
Where A9599 sits
- 1A codesAmbulance, supplies and miscellaneous
- 2Terminated A9599Radiopharmaceutical, diagnostic, for beta-amyloid positron emission tomography (pet) imaging, per study dose, not otherwise specified
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
Is HCPCS code A9599 still valid?
No. CMS terminated A9599; its last date of service was Dec 31, 2017. It is listed for looking up services from before then. Use a current code for newer services.
Does Medicare cover A9599?
CMS lists A9599’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Other carrier priced”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside A9599
All A codesA9593Gallium ga-68 psma-11, diagnostic, (ucsf), 1 millicurieA9594Gallium ga-68 psma-11, diagnostic, (ucla), 1 millicurieA9595Piflufolastat f 18 (pylarify), diagnostic, 1 millicurieA9596Gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurieA9597Positron emission tomography radiopharmaceutical, diagnostic, for tumor identification, not otherwise classifiedA9598Positron emission tomography radiopharmaceutical, diagnostic, for non-tumor identification, not otherwise classifiedA9600Strontium sr-89 chloride, therapeutic, per millicurieA9601Flortaucipir f 18 injection, diagnostic, 1 millicurieA9602Fluorodopa f-18, diagnostic, per millicurieA9603Injection, pafolacianine, 0.1 mgA9604Samarium sm-153 lexidronam, therapeutic, per treatment dose, up to 150 millicuriesA9606Radium ra-223 dichloride, therapeutic, per microcurie